Curis Announces the Receipt of Second Extension of Funding from Genentech

News   Oct 14, 2005

 
Curis Announces the Receipt of Second Extension of Funding from Genentech
 
 
 

RELATED ARTICLES

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

READ MORE

Molecule Prevents Common Cold Virus from Hijacking Human Cells

News

Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.

READ MORE

Improving Pharmaceuticals: Catalyst Specifically Tuned to Integrate Fluorine Atoms

News

In the race to create more potent and stable medicines, scientists know that adding fluorine can improve drug molecules. However, there is only one fluorination reaction known to occur in nature which is performed by complex and highly specialized enzymes that are difficult to replicate. Now, scientists have developed a new, streamlined molecule that can do the work of enzymes but be designed and controlled minutely.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE